Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study-Reference-Cited by-同舟云学术

Screening diabetic patients for non-alcoholic fatty liver disease with controlled attenuation parameter and liver stiffness measurements: a prospective cohort study

Published:2015-04-14 Issue:8 Volume:65 Page:1359-1368
ISSN:0017-5749
Container-title:Gut
language:en
Short-container-title:Gut

Author:

Kwok Raymond,Choi Kai Chow,Wong Grace Lai-Hung,Zhang Yuying,Chan Henry Lik-Yuen,Luk Andrea On-Yan,Shu Sally She-Ting,Chan Anthony Wing-Hung,Yeung Ming-Wai,Chan Juliana Chung-Ngor,Kong Alice Pik-Shan,Wong Vincent Wai-Sun

Publisher

BMJ

Subject

Gastroenterology

Reference39 articles.

1. Incidence of non-alcoholic fatty liver disease in Hong Kong: A population study with paired proton-magnetic resonance spectroscopy;Wong;J Hepatol,2015

2. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years;Wong;Gut,2010

3. The incidence and risk factors of hepatocellular carcinoma in patients with nonalcoholic steatohepatitis;Ascha;Hepatology,2010

4. The natural history of nonalcoholic fatty liver disease with advanced fibrosis or cirrhosis: an international collaborative study;Bhala;Hepatology,2011

5. How common is non-alcoholic fatty liver disease in the Asia-Pacific region and are there local differences?;Amarapurkar;J Gastroenterol Hepatol,2007

Cited by 396 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes as a risk factor for MASH progression;Diabetes Research and Clinical Practice;2024-11

2. Seabuckthorn polysaccharides mitigate hepatic steatosis by modulating the Nrf-2/HO-1 pathway and gut microbiota;AMB Express;2024-09-09

3. Associations of very low Lipoprotein(a) levels with risks of new-onset diabetes and non-alcoholic liver disease;Atherosclerosis Plus;2024-09

4. An Australian Community-Based Metabolic Dysfunction-Associated Steatotic Liver Disease Care Pathway for People with Type 2 Diabetes: Barriers and Considerations;Patient Preference and Adherence;2024-09

5. Liver fibrosis according to diabetes status and relation to cardiovascular risk and mortality in US adults;American Heart Journal Plus: Cardiology Research and Practice;2024-09